JW (CAYMAN) THERAPEUTICS CO. LTD
(HKEX: 2126)
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
2.550 -
+0.060
(+2.41%)
Range
2.470 - 2.580
(4.45%)
Open
2.500
Previous Close
2.490
Bid Price
2.530
Bid Volume
('000)
10
Ask Price
2.550
Ask Volume
('000)
1
Volume
('000)
888
Value
2,258,460
Remark
-
Delayed prices. Updated at 30 Jan 2026 00:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
